Table 2. Correlation between hs-cTn-I and clinical variables in patients with RA and controls.
RA Patients (n = 164) | Controls (n = 90) | |||
Variable | rho | P* | rho | P* |
Age | 0.359 | <0.001 | 0.172 | 0.104 |
Body mass index | −0.142 | 0.069 | 0.026 | 0.806 |
Systolic blood pressure | 0.248 | 0.001 | 0.297 | 0.005 |
Coronary calcium score | 0.330 | <0.001 | 0.298 | 0.005 |
HDL cholesterol | 0.066 | 0.402 | −0.056 | 0.605 |
LDL cholesterol | 0.174 | 0.027 | 0.154 | 0.15 |
Homocysteine | 0.166 | 0.035 | 0.088 | 0.409 |
Creatinine | 0.145 | 0.064 | 0.306 | 0.003 |
TNFa | 0.148 | 0.061 | −0.106 | 0.321 |
IL-6 | 0.093 | 0.243 | −0.144 | 0.188 |
C-reactive protein | −0.086 | 0.275 | 0.166 | 0.119 |
NT-proBNP | 0.255 | 0.001 | 0.062 | 0.567 |
Disease Duration | 0.197 | 0.012 | N/A | N/A |
DAS28 | 0.037 | 0.638 | N/A | N/A |
Erythrocyte sedimentation rate | −0.014 | 0.863 | N/A | N/A |
P values by Spearman’s correlation coefficient test.